In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein.
about
Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factorsThe Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressorDifferential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIFMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.Evaluation of a prediction protocol to identify potential targets of epigenetic reprogramming by the cancer associated Epstein Barr virusA subset of replication proteins enhances origin recognition and lytic replication by the Epstein-Barr virus ZEBRA protein.Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, ZtaSumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus.Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly.The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsContribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cellsRole of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activaCCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1)YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter.Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitorsCyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6.Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction.Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replicationA replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.Human cytomegalovirus UL84 interacts with an RNA stem-loop sequence found within the RNA/DNA hybrid region of oriLyt.Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latencyA class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly.RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanismSerine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation
P2860
Q22253362-DF2BAEC3-E053-47A0-89C3-0A13F097B5FEQ24558692-896449FE-92D7-4F1C-A57F-1DDCCFDA7876Q24619491-D1CE3DE8-6D57-4462-8549-AC5E80EDC5E6Q24649809-5E56A9C8-3380-44CD-9B71-B4C7F1A6EEA6Q28472086-45B05919-25CE-4699-9EF7-3DBFCE489897Q28480586-8CD17D77-AC76-4F59-80E9-9DE37A344D83Q30450300-219BE60E-37DC-4754-B850-A4269BBE7EFDQ33321474-8F2E0EBB-F9EE-466F-AC56-6AFD089F2434Q33535848-AB16EA85-9546-494D-B2FB-C5BC3E5787B8Q33680762-E07010E0-272E-46C9-A344-F9B4D81601D9Q33822549-883800E1-2620-469B-886D-6B2A533F5E24Q33826641-18E47E3E-8D02-42F1-B899-733EEBA3AB46Q33836726-09516050-DFC5-48E8-9B1A-6BD1FC462307Q33877497-FF805A2C-9FCE-430D-943C-041F418F6CA2Q33919771-73F3B191-7CBB-404C-B061-737205376E55Q33936163-7BFDF439-DB1C-4A04-9266-69C6FBFDCA5FQ34061465-B40A0B03-3069-4EC3-B9BE-500CDA4FE44EQ34120915-EB29E6AF-79B5-4D3E-83D0-BFB39D907778Q34281562-554234F3-157D-4923-BB88-1A636480BD88Q34291099-D48C4ACA-A886-447C-B12A-1C86395E462CQ34302078-EDAEF10B-E4A3-409A-814E-FF259DC9FA27Q34461819-BFEBBF47-CF56-499D-92F7-F8D71F0341E3Q34465924-0B394A4F-1E27-4DE6-8357-675A771979EEQ34751026-222843EB-C73B-4F52-B044-7A46BE110D1CQ35024349-A6E4172F-C85B-406C-A619-2CA6C665A01CQ35122852-A4446BB9-8067-4566-B873-E7B2AA75E65CQ35182098-9AA32064-5EDF-4ECA-BE12-297F4C3C7A45Q35841116-96FAD0C3-CC39-4321-B61C-60D370C87A41Q35841284-569FF069-F486-41CC-9030-6AF467134BC1Q35851139-DC17CC7E-B164-4D2A-BE14-1FD8B397CF51Q35857052-E8701650-AED5-4327-ADBA-8623F8AEF57EQ35861789-54263859-A76C-442C-B466-09068752052AQ35865903-54BB9D22-70D6-4839-AB7D-FE5D1D1A2954Q35873179-FD5A4C3B-F5E0-4D5E-9DD5-5E6E9B9008D0Q35881137-DC32F990-A59A-427C-9159-1611896466D6Q35914395-16315AE5-A0EA-4388-88FC-4A2F2E3ABC80Q36298743-9E549D66-174C-4F4C-AA15-F381B2521FA1Q36556030-FFE51F80-1EB1-46D8-BF42-9B1B934BCB01Q36630074-AB7CEC14-94A5-4FFF-9426-7FF8DDBE3C03Q36634417-9C798CC4-ABFD-45F9-80D3-E311A61972F5
P2860
In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
In vitro transcriptional activ ...... pstein-Barr virus Zta protein.
@ast
In vitro transcriptional activ ...... pstein-Barr virus Zta protein.
@en
type
label
In vitro transcriptional activ ...... pstein-Barr virus Zta protein.
@ast
In vitro transcriptional activ ...... pstein-Barr virus Zta protein.
@en
prefLabel
In vitro transcriptional activ ...... pstein-Barr virus Zta protein.
@ast
In vitro transcriptional activ ...... pstein-Barr virus Zta protein.
@en
P2860
P1433
P1476
In vitro transcriptional activ ...... pstein-Barr virus Zta protein.
@en
P2093
P M Lieberman
P2860
P304
P407
P577
1990-06-01T00:00:00Z